 "market")
Shares of Thyrocare Technologies moved higher by 15 per cent to Rs 883, also its record high on the BSE on Tuesday, after the company reported nearly 37 per cent year-on-year and over 100 per cent sequential growth in aggregate revenue for the quarter ended September 2020 (Q2FY21). The stock of healthcare services provider has now surpassed its previous high of Rs 845.25 touched on August 17, 2020.
“Q2FY21 has witness a motivating numbers and increased turnover of Covid-PCR and Covid-Antibody testing, and the aggregate revenue for the quarter, has increased by about 37 per cent compared to Q2FY20.
“Q2FY21 has witness a motivating numbers and increased turnover of Covid-PCR and Covid-Antibody testing, and the aggregate revenue for the quarter, has increased by about 37 per cent compared to Q2FY20.
